Ruxolitinib takes center stage for VEXAS syndrome
Blood
.
2022 Aug 25;140(8):807-808.
doi: 10.1182/blood.2022017056.
Author
Richard Conway
1
Affiliation
1
Trinity College Dublin.
PMID:
36006674
DOI:
10.1182/blood.2022017056
No abstract available
Publication types
Editorial
Comment
MeSH terms
Janus Kinase Inhibitors*
Nitriles
Pyrazoles / therapeutic use
Pyrimidines
Retrospective Studies
Substances
Janus Kinase Inhibitors
Nitriles
Pyrazoles
Pyrimidines
ruxolitinib